How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
Community PollStarted
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
75 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Geriatric Medicine · University of Minnesota
Answered on
Depends who you read.
- ACP: Recommendation 4: ACP recommends against bone density monitoring during the 5-year pharmacologic treatment period for osteoporosis in women. (Grade: weak recommendation; low-quality evidence) [1]
- Monitoring wasn't addressed in the 2023 update.
- ACR: For adults continuing...
Join for free or sign in to see the full answer